Life Sciences Insights | McKinsey Company This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations
Driving life sciences growth from productivity to performance “ Clear, credible, compelling: Mastering investor engagement in life sciences ” explores how life sciences companies can strengthen investor relations by sharpening their equity stories, reinforcing credibility with proof points, and sustaining confidence through periods of volatility
McKinsey Healthcare Practice: Complete Guide (2026) McKinsey's healthcare practice has more than 1,700 consultants across 70-plus countries serving payers, providers, pharma, and medtech Learn what the practice does, how it is structured, its research centers, real project examples, how to get hired, and what the interviews are like
Transforming Healthcare and Life Sciences: Key Insights from McKinsey On May 31, 2025, a McKinsey survey revealed that 85% of leaders in healthcare—from payers to technology groups—are currently exploring or using generative AI technologies In the life sciences sector, generative AI could potentially unlock between $60 billion to $110 billion in value
A path forward for pharma commercial leaders | McKinsey Biopharmaceutical commercial leaders are experiencing a period of substantial disruption that is likely to continue for the foreseeable future Commercial capabilities once considered sufficient are no longer adequate or fit for purpose
Transformations for life sciences companies | McKinsey Against this backdrop, we examined some 30 successful transformations undertaken by life sciences companies in the past five years, seeking to understand what has made them exceptions to the rule We found that all adhered to five transformation principles that we believe help explain their success
Outlook on pharma operations - McKinsey Company A McKinsey study of over 30 global pharmacos shows average annual productivity increases of 7% over the past four years, which implies that productivity would double in a decade